| Date | Title | Description |
| 02.05.2024 | ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions | EINDHOVEN, the Netherlands, May 02, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), a medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people ... |
| 05.04.2024 | Swiss healthcare innovators tap into the US market |
Basel-based startup Basilea Pharmaceutica announced the FDA approval of ZEVTERA, their antibacterial treatment of adult patients with Staphylococcus aureus bloodstream infections (bacteremia), adult patients with acute bacterial skin and s... |
| 26.03.2024 | ONWARD Medical Secures €20 Million for Spinal Cord Therapies | ONWARD Medical, a pioneer in spinal cord stimulation therapies, has successfully raised €20 million through a strategic offering. The company's innovative treatments aim to restore movement and independence for individuals with spinal cord ... |
| 25.03.2024 | ONWARD Medical Raises €20 Million |
ONWARD Medical creates innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and movement disorders. The company raised €20 million in gross proceeds by way of ... |
| 25.03.2024 | ONWARD Medical raises EUR 20 Million for spinal cord injury products | ONWARD Medical, a company focusing on innovative spinal cord injuries and movement disorders therapies, recently raised EUR 20 million through private and public offerings. These funds will primarily support research and development activit... |
| 25.03.2024 | ONWARD Medical raises EUR 20 Million for spinal cord injury products | ONWARD Medical raises EUR 20 Million for spinal cord injury products 25.03.2024 16:13, Rita Longobardi linkedIn facebook twitter instagram youtube -->
ONWARD Medical secures EUR 20 million in funding through private placement and public ... |
| 26.01.2024 | New milestones for life sciences startups |
BioVersys AG is a clinical stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies for life-threatening multidrug-resistant bacterial infections and targeted microbiome modulation. The company is d... |
| 06.11.2023 | This spinal implant tech could restore mobility to Parkinson’s patients | People with Parkinson’s disease are being diagnosed earlier and living with the condition for longer periods as treatments evolve, but one stubborn late-arriving symptom is trouble walking. A promising new spinal implant from Swiss research... |
| 19.10.2023 | Global accelerators propel Swiss life sciences | |
| 14.09.2023 | ONWARD on the verge of entering the U.S. Federal Health Market | |
| 14.09.2022 | ONWARD’s therapy improves hand and arm function in people with spinal chord injury | |
| 07.09.2022 | Support for Swiss startups | |
| 10.05.2022 | First-in-Human Use of ONWARD’s Implantable Neurostimulator | |
| 13.04.2022 | ONWARD Announces Additions to Leadership Team | Lara Smith Weber to join the company as CFO and Zouhir Mechta to join as VP Operations. |
| 07.04.2022 | ONWARD Medical’s Parkinson’s therapy published in New England Journal of Medicine | ONWARD Medical today announces an important publication in the New England Journal of Medicine (NEJM), highlighting the use of ONWARD’s innovative approach to treating orthostatic hypotension in a patient with MSA-P, a degenerative nervous ... |
| 28.03.2022 | ONWARD adds new brain-spine interface and Parkinson’s disease IP to license agreements | ONWARD Medical today announces two new innovations have been added to its portfolio of license agreements with the Swiss Federal Institute of Technology Lausanne (EPFL), one of the world’s preeminent neuroscience research institutions, and ... |
| 25.03.2022 | Tech Tour and Viva Tech nominate Switzerland’s growth startups | |
| 09.03.2022 | First Participants Enrolled in ONWARD’s LIFT Home Study | ONWARD Medical today announces the start of enrollment in the LIFT Home Study. The trial is designed to study the safety and performance of ARCEX Therapy when used in the home. |
| 08.03.2022 | Scale Up Vaud attracts record number of new scale-ups and investment | |
| 07.02.2022 | Onward Medical N : Technology Enables Walking and Standing After Severe Spinal Cord Injuries | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE
EUROPEAN MARKET ABUSE REGULATION (596/2014).
ONWARD Medical's Technology Enables Walking and
Standing After Severe Spinal Cord Injuries
STIMO-BRIDGE St... |
| 07.02.2022 | ONWARD Medical: STIMO-BRIDGE study results published in Nature Medicine | ONWARD Medical today announces the publication of STIMO-BRIDGE Study results in Nature Medicine. The study highlights the use of ONWARD’s technology to enable people with even the most severe forms of spinal cord injury to walk, stand, cycl... |
| 19.01.2022 | Onward Medical N : Announces Participation at Upcoming Degroof Petercam Healthcare Conference | ONWARD Announces Participation at Upcoming Degroof
Petercam Healthcare Conference
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland-January 19, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovat... |
| 16.12.2021 | ONWARD Announces Completion of Enrollment in the Up- LIFT Pivotal Trial of ARC Therapy for Spinal Cord Injury | ONWARD, today announces it has completed enrollment in the Up-LIFT study, a pivotal trial to evaluate the safety and effectiveness of ARC Therapy to restore hand and arm function in people with spinal cord injury (SCI). Up-LIFT is the first... |
| 21.10.2021 | ONWARD Medical raises CHF93 million in IPO | |
| 06.07.2021 | Patient advocacy groups and innovators must partner to advance new treatments | People living with debilitating conditions and life-threatening diseases are often put in the terrible position of having to wait — even though they lack the luxury of time — for scientific advances that take years to reach the market, prev... |
| 25.05.2021 | Medtech and Cleantech startups in the global spotlight | |
| 25.05.2021 | Medtech and Cleantech startups in the global spotlight | Onward Medical –Medical Device Engineering Breakthrough” Award
This year’s Medical Device Engineering Breakthrough” Award program attracted more than 3,850 nominations from over 17 different countries worldwide. MedTech Breakthrough, an ind... |
| 06.05.2021 | ONWARD Wins “Medical Device Engineering Breakthrough” Award in 2021 MedTech Breakthrough Awards Program | This potentially life-changing technology is the reason we created this awards program, and we extend our sincere congratulations to ONWARD for winning our ‘Medical Device Engineering Breakthrough’ award for our 2021 MedTech Breakthrough Aw... |
| 23.04.2021 | Fresh capital for ONWARD to tackle spinal code injuries | ONWARD’s ARC therapy can be delivered by an implantable system called ARC-IM and an external system called ARC-EX. Both platforms are designed to deliver targeted, programmed stimulation of the spinal cord to restore movement, independence,... |
| 23.04.2021 | Fresh capital for ONWARD to tackle spinal cord injuries | |
| 23.04.2021 | Swiss-Dutch startup Onward raises €26.5M to enable people with spinal cord injury to move again; here’s how | Eindhoven, Netherlands-based Onward is a medical technology company that creates innovative therapies to restore movement, independence, and health in people with spinal cord injury.Onward raises funding
In a recent development, the company... |
| 22.04.2021 | ONWARD raises USD 32M to further develop and commercialize their ARC therapy stimulating the spinal cord to restore movement | ONWARD is a spin-off company from Professor Courtine’s laboratory at the École Polytechnique Fédérale de Lausanne (EPFL, Switzerland), with offices in Switzerland and the Netherlands. The Company is developing an Implantable Neuro-stimulati... |
| 22.04.2021 | ONWARD raises USD 32M to further develop and commercialize their ARC therapy stimulating the spinal cord to restore movement | ONWARD raises USD 32M to further develop and commercialize their ARC therapy stimulating the spinal cord to restore movement 22.04.2021 18:29, Guillaume Tinsel linkedIn facebook twitter instagram youtube -->
The round was led by Invest-N... |
| 13.01.2021 | Promising therapy for patients with spinal cord injuries advances to the next stage | ONWARD is focused on developing and commercialising innovative therapies to facilitate functional recovery of people with spinal cord injury. Driven by a mission to restore movement, independence, and health in people with spinal cord injur... |
| 13.01.2021 | Promising therapy for patients with spinal cord injuries advances to the next stage | |
